Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders

              Stockholders to Vote on Transactions with Misys



    CHICAGO, Aug. 22 /EMWNews/ -- Allscripts Healthcare

Solutions, Inc. ("Allscripts"), the leading provider of clinical software,

connectivity and information solutions that physicians use to improve

healthcare, announced today that it filed a definitive proxy statement with

the U.S. Securities and Exchange Commission on Thursday, August 21, 2008 in

respect of the proposed transactions involving Allscripts, Misys plc

("Misys") and Misys Healthcare Systems LLC ("MHS"), a wholly owned

subsidiary of Misys, as announced on March 18, 2008. Allscripts further

announced that it will hold its annual meeting of stockholders on Monday,

September 22, 2008, at 10:00 a.m. Central Time, to approve certain actions

required to be taken by Allscripts in connection with the proposed

transactions, among other matters. The meeting will be held at One South

Dearborn Street, Chicago, Ill. For more information, please see the

definitive proxy statement.



    



    The Allscripts board of directors has approved the merger agreement

with Misys and recommends approval of the share issuance and related

transactions contemplated by the merger agreement by Allscripts

stockholders. Completion of the transaction is subject to certain

conditions, including approvals by the stockholders of Allscripts and the

shareholders of Misys and other customary closing conditions. Subject to

the satisfaction of these closing conditions, the transactions are expected

to be completed on or about September 26, 2008.

    About Allscripts



    Allscripts (Nasdaq: MDRX) is the leading provider of clinical software,

connectivity and information solutions that physicians use to improve

healthcare. The company's unique solutions inform, connect and transform

healthcare, delivering improved care at lower cost. More than 40,000

physicians and thousands of other healthcare professionals in clinics,

hospitals and extended care facilities nationwide utilize Allscripts to

automate everyday tasks such as writing prescriptions, documenting patient

care, managing billing and scheduling, and safely discharging patients, as

well as to connect with key information and stakeholders in the healthcare

system. To learn more, visit http://www.allscripts.com.



    Additional Information and Where to Find It



    This communication is being made in respect of the proposed business

combination involving a subsidiary of Allscripts and MHS, a wholly owned

subsidiary of Misys. In connection with this proposed transaction,

Allscripts has filed with the Securities and Exchange Commission (the

"SEC") a definitive proxy statement. On August 22, 2008, Allscripts is

mailing the definitive proxy statement and proxy card to its stockholders

of record as of August 15, 2008. BEFORE MAKING ANY DECISION WITH RESPECT TO

THE PROPOSED TRANSACTION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ

THE PROXY STATEMENT AND OTHER RELEVANT MATERIALS WHEN THEY BECOME

AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE

COMPANY AND THE PROPOSED TRANSACTION. Investors and security holders can

obtain copies of Allscripts' materials (and all other offer documents filed

with the SEC) when available, at no charge on the SEC's website:

http://www.sec.gov. Copies can also be obtained at no charge by directing a

request for such materials to Allscripts at 222 Merchandise Mart Plaza,

Suite 2024, Chicago, Illinois 60654, Attention: Lee Shapiro, Secretary.

Investors and security holders may also read and copy any reports,

statements and other information filed by Allscripts with the SEC, at the

SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549.

Please call the SEC at 1-800-SEC-0330 or visit the SEC's website for

further information on its public reference room. Allscripts' directors,

executive officers and other members of management and employees may, under

the rules of the SEC, be deemed to be participants in the solicitation of

proxies from the stockholders of Allscripts in favor of the proposed

transaction. Information about Allscripts, its directors and its executive

officers, and their ownership of Allscripts' securities, is set forth in

its definitive proxy statement for the 2008 Annual Meeting of Stockholders

of the Company, which was filed with the SEC on August 21, 2008.



    Forward-Looking Statements



    This communication contains forward-looking statements. Those

forward-looking statements include all statements other than those made

solely with respect to historical fact. Forward-looking statements may be

identified by words such as "believes", "expects", "anticipates",

"estimates", "projects", "intends", "should", "seeks", "future", continue",

or the negative of such terms, or other comparable terminology. Such

statements include, but are not limited to, statements about the expected

benefits of the transaction involving Allscripts, MHS and Misys, including

potential synergies and cost savings, future financial and operating

results, and the combined company's plans and objectives. In addition,

statements made in this communication about anticipated financial results,

future operational improvements and results or regulatory approvals are

also forward-looking statements. Such forward-looking statements are

subject to numerous risks, uncertainties, assumptions and other factors

that are difficult to predict and that could cause actual results to vary

materially from those expressed in or indicated by them. Such factors may

include, but are not limited to: (1) the occurrence of any event,

development, change or other circumstances that could give rise to the

termination of the merger agreement; (2) the outcome of any legal

proceedings that have been or may be instituted against Allscripts, Misys

or MHS and others following announcement of entering into the merger

agreement; (3) the inability to complete the proposed transaction due to

the failure to obtain stockholder or shareholder approval or the failure of

any party to satisfy other conditions to completion of the proposed

transaction; (4) risks that the proposed transaction disrupts current plans

and operations and potential difficulties in employee retention as a result

of the merger; (5) the ability to recognize the benefits of the merger; (6)

legislative, regulatory and economic developments; and (7) other factors

described in filings with the SEC. Many of the factors that will determine

the outcome of the subject matter of this communication are beyond

Allscripts', Misys' and MHS' ability to control or predict. Allscripts can

give no assurance that any of the transactions related to the merger will

be completed or that the conditions to the merger will be satisfied.

Allscripts undertakes no obligation to revise or update any forward-looking

statement, or to make any other forward-looking statements, whether as a

result of new information, future events or otherwise. Allscripts is not

responsible for updating the information contained in this communication

beyond the published date, or for changes made to this communication by

wire services or Internet service providers.